Xavier F Bosch

Summary

Country: Spain

Publications

  1. pmc Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:13630-40. 2005
  2. pmc Human Papillomavirus type distribution in invasive cervical cancer in Uganda
    Michael Odida
    Department of Pathology, Faculty of Medicine, Makerere University, Kampala, Uganda
    BMC Infect Dis 8:85. 2008
  3. pmc The causal relation between human papillomavirus and cervical cancer
    F X Bosch
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Gran Via Km 2 7 s n 08907 L Hospitalet de Llobregat, 08907 Barcelona, Spain
    J Clin Pathol 55:244-65. 2002
  4. ncbi request reprint The epidemiology of human papillomavirus infection and cervical cancer
    F Xavier Bosch
    Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, E 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Dis Markers 23:213-27. 2007
  5. ncbi request reprint Prevention strategies of cervical cancer in the HPV vaccine era
    Xavier Bosch
    Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, Avda Gran Via s n Km 2, 708907 L Hospitalet de Llobregat, Barcelona, Spain
    Gynecol Oncol 103:21-4. 2006
  6. ncbi request reprint Epidemiology of hepatocellular carcinoma
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit, IDIBELL, Institut Catala d Oncologia, Avda Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Clin Liver Dis 9:191-211, v. 2005
  7. ncbi request reprint Primary liver cancer: worldwide incidence and trends
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit, IDIBELL Institut Català d Oncologia, Avda Gran Via s n, Km 2 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Gastroenterology 127:S5-S16. 2004
  8. ncbi request reprint Human papillomavirus in cervical cancer
    F Xavier Bosch
    Servei dEpidemiologia i Registre del Càncer, Institut Català dOncologia, Av Gran Via, s n km 2 7, 08907 LHospitalet de Llobregat, Barcelona, Spain
    Curr Oncol Rep 4:175-83. 2002
  9. pmc Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference
    F X Bosch
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    J Clin Pathol 54:163-75. 2001
  10. ncbi request reprint Epidemiology of human papillomavirus infections: new options for cervical cancer prevention
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit SERC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Avenida Gran Via, s n km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Salud Publica Mex 45:S326-39. 2003

Detail Information

Publications79

  1. pmc Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:13630-40. 2005
    ..Some had one, two, or three amino acid substitutions in these regions, which might indicate biological and pathogenic diversity between the variants of each HPV type...
  2. pmc Human Papillomavirus type distribution in invasive cervical cancer in Uganda
    Michael Odida
    Department of Pathology, Faculty of Medicine, Makerere University, Kampala, Uganda
    BMC Infect Dis 8:85. 2008
    ..We conducted a study aiming to describe Human Papillomavirus (HPV) type distribution in invasive cervical carcinoma in Uganda...
  3. pmc The causal relation between human papillomavirus and cervical cancer
    F X Bosch
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Gran Via Km 2 7 s n 08907 L Hospitalet de Llobregat, 08907 Barcelona, Spain
    J Clin Pathol 55:244-65. 2002
    ..It is the right time for medical societies and public health regulators to consider this evidence and to define its preventive and clinical implications. A comprehensive review of key studies and results is presented...
  4. ncbi request reprint The epidemiology of human papillomavirus infection and cervical cancer
    F Xavier Bosch
    Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, E 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Dis Markers 23:213-27. 2007
    ..Women exposed to the Human Immunodeficiency Virus (HIV) are at high risk for HPV infection, HPV DNA persistency and progression of HPV lesions to cervical cancer...
  5. ncbi request reprint Prevention strategies of cervical cancer in the HPV vaccine era
    Xavier Bosch
    Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, Avda Gran Via s n Km 2, 708907 L Hospitalet de Llobregat, Barcelona, Spain
    Gynecol Oncol 103:21-4. 2006
  6. ncbi request reprint Epidemiology of hepatocellular carcinoma
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit, IDIBELL, Institut Catala d Oncologia, Avda Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Clin Liver Dis 9:191-211, v. 2005
    ..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
  7. ncbi request reprint Primary liver cancer: worldwide incidence and trends
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit, IDIBELL Institut Català d Oncologia, Avda Gran Via s n, Km 2 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Gastroenterology 127:S5-S16. 2004
    ..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
  8. ncbi request reprint Human papillomavirus in cervical cancer
    F Xavier Bosch
    Servei dEpidemiologia i Registre del Càncer, Institut Català dOncologia, Av Gran Via, s n km 2 7, 08907 LHospitalet de Llobregat, Barcelona, Spain
    Curr Oncol Rep 4:175-83. 2002
    ....
  9. pmc Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference
    F X Bosch
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    J Clin Pathol 54:163-75. 2001
    ..This leader summarises the highlights presented at the conference (the full text of the abstracts and lectures can be found at www.hpv2000.com). Relevant material in Spanish can be found at www.aepcc.org...
  10. ncbi request reprint Epidemiology of human papillomavirus infections: new options for cervical cancer prevention
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit SERC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Avenida Gran Via, s n km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Salud Publica Mex 45:S326-39. 2003
    ..Time is ripe for exploring in depth the clinical implications of current achievements and to devise novel strategies for the prevention of cervical cancer. This paper is available too at: http://www.insp.mx/salud/index.html...
  11. ncbi request reprint The viral etiology of cervical cancer
    F Xavier Bosch
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Hospital Duran i Reynals, Gran Via km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Virus Res 89:183-90. 2002
    ..This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings...
  12. doi request reprint Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
    Silvia de Sanjose
    IDIBELL, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Lancet Oncol 11:1048-56. 2010
    ..We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer...
  13. ncbi request reprint [Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners]
    S de Sanjose
    Servicio de Epidemiología y Registro del Cáncer, Institut Catala d Oncologia, Barcelona
    Med Clin (Barc) 115:81-4. 2000
    ..The study was designed to estimate the prevalence of HPV infection and the related risk of cervical cancer among imprisoned women...
  14. doi request reprint The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe
    Josepa Ribes
    Catalan Cancer Plan, IDIBELL, Catalan Institute of Oncology, Avda Gran Via s n, Km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    J Hepatol 49:233-42. 2008
    ..To assess the variability of liver cancer (LC) risk associated with hepatitis B (HBV) and hepatitis C (HCV) viruses and alcohol intake in 2002 throughout Europe...
  15. pmc Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries
    K S Louie
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Hospitalet del Llobregat Barcelona, Barcelona, Spain
    Br J Cancer 100:1191-7. 2009
    ..These data confirm AFSI and AFB as risk factors for ICC in eight developing countries, but any independent effects of these two events could not be distinguished...
  16. ncbi request reprint Epidemiology of liver cancer in Europe
    F X Bosch
    L Hospitalet de Llobregat, Barcelona, Spain
    Can J Gastroenterol 14:621-30. 2000
    ....
  17. ncbi request reprint Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
    Lancet Infect Dis 7:453-9. 2007
    ..The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women...
  18. pmc Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population
    M Paz Cañadas
    Departament de Biologia Molecular, General Lab, Barcelona, Spain
    J Clin Microbiol 42:1330-2. 2004
    ..HPV was found in 43.6% of the women, and its prevalence at genital sites was similar. Prevalence was highest among women aged 20 years or younger but declined thereafter in specimens from all anogenital sites...
  19. pmc Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
    Xavier Castellsague
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
    BMC Infect Dis 9:74. 2009
    ..Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results...
  20. pmc Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
    M Diaz
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology ICO, Av Gran Via, s n km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Br J Cancer 99:230-8. 2008
    ....
  21. doi request reprint Human papillomavirus prevalence and type distribution in penile carcinoma
    C Miralles-Guri
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, L Hospitalet de Ll, Barcelona, Spain
    J Clin Pathol 62:870-8. 2009
    ..HPV prevalence in penile tumours is reported to be associated to a variety of morphological changes. Its determination will provide a better estimate for HPV related cancer burden and its preventable fraction...
  22. doi request reprint Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings
    Laia Bruni
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL Institut Català d Oncologia, Barcelona, Spain
    J Infect Dis 202:1789-99. 2010
    ..Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the near future...
  23. pmc HPV and cervical cancer: screening or vaccination?
    F X Bosch
    Cancer Epidemiology and Registration Unit, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
    Br J Cancer 98:15-21. 2008
    ..Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition...
  24. ncbi request reprint [Incidence and survival of leukemias according to the different histologic subsets, in Tarragona, Spain, between 1980-1994]
    J R Gonzalez
    Servicio de Prevencion y Control del Cancer Institut Catala d Oncologia L Hospitalet de Llobregat Barcelona
    Med Clin (Barc) 116:174-8. 2001
    ..To study the incidence and survival of leukemias according to the different histologic types in Tarragona, Spain...
  25. ncbi request reprint Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up
    Josepa Ribes
    Epidemiology and Cancer Registration, Institut Catala d Oncologia, and Blod Bank, Hospital Universitari de Bellvitge, Hospitalet del Llobregat, Spain
    Int J Cancer 119:687-94. 2006
    ..These results support screening and adequate follow-up among HBsAg-positive subjects at high risk to develop liver disease, particularly when these risk cofactors are present...
  26. ncbi request reprint Epidemiologic classification of human papillomavirus types associated with cervical cancer
    Nubia Munoz
    International Agency for Research on Cancer, Lyons, France
    N Engl J Med 348:518-27. 2003
    ..Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed...
  27. ncbi request reprint Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention
    Xavier Castellsague
    Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
    J Natl Cancer Inst 98:303-15. 2006
    ..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear...
  28. ncbi request reprint Time trends in incidence and mortality for chronic liver disease and liver cancer in the interval 1980-1997 in Catalonia, Spain
    Josepa Ribes
    Servei d Epidemiologia i Registre del Càncer Institut Català, d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Eur J Gastroenterol Hepatol 16:865-72. 2004
    ..The purpose of this study was to examine time trends of incidence and mortality rates of liver cirrhosis and liver cancer for the period 1980-1997 in Catalonia, Spain...
  29. ncbi request reprint Against which human papillomavirus types shall we vaccinate and screen? The international perspective
    Nubia Munoz
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:278-85. 2004
    ..The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs...
  30. ncbi request reprint Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men
    Xavier Castellsague
    Cancer Epidemiology and Registration Unit, Institut d Investigacio Biomedica de Bellvitge, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Am J Epidemiol 162:907-16. 2005
    ..These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners...
  31. ncbi request reprint Environmental co-factors in HPV carcinogenesis
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Vias n km 2, 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Virus Res 89:191-9. 2002
    ....
  32. ncbi request reprint Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
    N Engl J Med 346:1105-12. 2002
    ..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner...
  33. ncbi request reprint Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study
    Victor Moreno
    Epidemiology and Cancer Registry Service, Catalan Institute of Oncology, Hospital Duran i Reynals, L Hospitalet de Llobregat, Barcelona, Spain
    Lancet 359:1085-92. 2002
    ..We aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA...
  34. ncbi request reprint Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study
    Silvia de Sanjose
    Institut Catala d Oncologia, Hospitalet de LL, Barcelona, Spain
    Int J Cancer 106:588-93. 2003
    ..The contribution of these genes to early-onset breast cancer is likely to be even higher given that certain UV cases might be disease-associated...
  35. ncbi request reprint Cervical human papillomavirus infection in the female population in Barcelona, Spain
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Via km 2 7 E 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Sex Transm Dis 30:788-93. 2003
    ..Human papillomavirus (HPV) is a major cause of invasive cervical cancer. Identification of HPV determinants might allow for targeting of high-risk groups for cervical cancer...
  36. ncbi request reprint The male role in cervical cancer
    Xavier Castellsague
    Institut Catala d Oncologia, Servel d Epidemiologia I Registre del Càncer, Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Salud Publica Mex 45:S345-53. 2003
    ..More research is needed to better understand the natural history and epidemiology of HPV infections in men. This paper is available too at: http://www.insp.mx/salud/index.html...
  37. ncbi request reprint Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 98:155-8. 2002
    ..All PBMC samples were negative. These results suggest that in low-risk countries for KSHV, oral shedding and heterosexual contacts are potential pathways for KSHV transmission...
  38. ncbi request reprint Role of hepatitis C virus infection in malignant lymphoma in Spain
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
    Int J Cancer 111:81-5. 2004
    ..HCV infection is associated with an increased risk of a broad spectrum of lymphoid neoplasms among non severely immunocompromised subjects in Spain...
  39. ncbi request reprint Epidemiology of primary liver cancer
    F X Bosch
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Semin Liver Dis 19:271-85. 1999
    ....
  40. ncbi request reprint The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis
    Xavier Castellsague
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 108:741-9. 2004
    ..These results underline the importance of type of tobacco and alcohol concentration in oral carcinogenesis...
  41. ncbi request reprint Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention
    Xavier Castellsague
    IDIBELL, Institut Català d Oncologia ICO, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 122:1901-4. 2008
    ..The introduction of an efficacious HPV 16/18 vaccine could potentially prevent the occurrence of 72% of cervical cancer cases and up to 81% of the cases if full cross-protection against HPVs 31 and 45 is assumed...
  42. ncbi request reprint Patient with hepatocellular carcinoma related to prior acute arsenic intoxication and occult HBV: epidemiological, clinical and therapeutic results after 14 years of follow-up
    Teresa Casanovas-Taltavull
    Department of Gastroenterology, Hospital Universitari de Bellvitge, IDIBELL, Feixa Llarga s n, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    World J Gastroenterol 12:1972-4. 2006
    ..At his most recent visit in May 2005, the patient was asymptomatic, liver enzymes were normal and the tumor was in remission on ultrasound...
  43. doi request reprint HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
    Xavier Castellsague
    Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, CIBER ESP, Barcelona, Spain
    Gynecol Oncol 115:S15-23. 2009
    ..We consider oncogenic HPV infection and the risk of developing cervical cancer in women over 25 years of age and whether they would also benefit from vaccination against HPV...
  44. doi request reprint HPV vaccines and cervical cancer
    F X Bosch
    Cancer Epidemiology Research Program CERP, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
    Ann Oncol 19:v48-51. 2008
  45. ncbi request reprint Diet and K-ras mutations in colorectal cancer
    V Moreno
    Catalan Institute of Oncology ICO, Barcelona, Spain
    IARC Sci Publ 156:501-2. 2002
  46. doi request reprint Human papillomavirus vaccines and vaccine implementation
    Silvia de Sanjose
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL and CIBER Epidemiología y Salud Pública CIBERESP, Barcelona, Spain
    Womens Health (Lond Engl) 4:595-604. 2008
    ..Finally, some major aspects that are likely to impact the introduction of these vaccines around the world are outlined, with particular emphasis on developing countries...
  47. doi request reprint Hospital deaths of people aged 90 and over: end-of-life palliative care management
    Francesc Formiga
    Geriatric Unit, Internal Medicine Service, Hospital Universitari de Bellvitge, L Hospitalet de Llobregat, Barcelona, Spain
    Gerontology 54:148-52. 2008
    ..In developed countries, hospital deaths at very advanced age are increasingly common. Few studies have addressed end-of-life care in very elderly patients with non-cancer chronic diseases...
  48. ncbi request reprint Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes
    Xavier Bosch
    Institut de Malalties Cardiovasculars, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Am Heart J 150:215-20. 2005
    ..This study examines whether the routine determination of left ventricular ejection fraction (EF) adds significant prognostic information to currently recommended stratifiers...
  49. ncbi request reprint Preface. The field of cervical cancer prevention
    F Xavier Bosch
    Epidemiology and Cancer Registry Unit, IDIBELL, Institut Catala d Oncologia, Avenida Gran Via s n, L Hospitalet de Llobregat, Barcelona, Spain
    Vaccine 24:S3/v-vi. 2006
  50. doi request reprint New insights in the management of cardiogenic shock complicating myocardial infarction: role of urgent heart transplantation
    Dabit Arzamendi
    Cardiology Unit, Cardio Thorax Institute Hospital Clinic de Barcelona, Barcelona, Spain
    J Heart Lung Transplant 27:984-9. 2008
    ..The primary end-point of the study was mortality at the 1-year follow-up...
  51. ncbi request reprint A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin
    Juan Sanchis
    Servei de Cardiologia, Hospital Clinic Universitari, Universitat de Valencia, Barcelona, Spain
    Am J Cardiol 99:797-801. 2007
    ....
  52. ncbi request reprint WAERS: an application for Web-assisted estimation of relative survival
    Ramon Clèries
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat Spain, Barcelona, Spain
    Med Inform Internet Med 32:169-75. 2007
    ..This application can be also useful for cohort mortality studies and for registries of several diseases...
  53. ncbi request reprint Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study
    Padmaja Patnaik
    Department of Epidemiology, CB 7435, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7435, USA
    Sex Transm Dis 34:1019-24. 2007
    ..To determine type-specific seroprevalence of herpes simplex viruses (HSV-1 and HSV-2) and HSV-2 risk factors...
  54. doi request reprint Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain
    Luis M Puig-Tintore
    Gynecologic Oncology, Hospital Clinic, University of Barcelona, Catalonia, Spain
    J Low Genit Tract Dis 12:82-9. 2008
    ..To quantify the coverage and monitor the factors associated with opportunistic cervical cytological screening in Spain...
  55. ncbi request reprint Risk factors of invasive cervical cancer in Mali
    Sine Bayo
    Institut National de Recherche en Sante Publique, Bamako, Mali
    Int J Epidemiol 31:202-9. 2002
    ..Cervical cancer is the most common cancer in women in Mali and the second commonest cause of cancer mortality...
  56. ncbi request reprint Is viral status needed before vaccination?
    Thomas C Wright
    Department of Pathology, Columbia University, Room 16 404, P and S Building, 630 West 168th Street, New York, NY, United States
    Vaccine 26:A12-5. 2008
    ..The increase in cost and the other barriers afforded by a prior to vaccination test requirement would result in a lower coverage, the key indicator of a successful vaccination program...
  57. ncbi request reprint Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
    ..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
  58. ncbi request reprint Aflatoxin, hepatitis and worldwide liver cancer risks
    Sara H Henry
    U S Food and Drug Administration, Washington, DC 20204, USA
    Adv Exp Med Biol 504:229-33. 2002
    ....
  59. ncbi request reprint Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
    Jennifer S Smith
    International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
    J Infect Dis 185:324-31. 2002
    ..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation...
  60. ncbi request reprint Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
    Jorma Paavonen
    University of Helsinki, Department of Obstetrics and Gynaecology, Helsinki, Finland
    Lancet 369:2161-70. 2007
    ....
  61. ncbi request reprint Cervical cancer control, priorities and new directions
    Joseph Monsonego
    EUROGIN, Paris, France
    Int J Cancer 108:329-33. 2004
    ..We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference...
  62. ncbi request reprint Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study
    Rolando Herrero
    International Agency for Research on Cancer, Lyon, France rherrero amnet co cr
    J Natl Cancer Inst 95:1772-83. 2003
    ..To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries...
  63. ncbi request reprint Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study
    Martyn Plummer
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
    Cancer Causes Control 14:805-14. 2003
    ..This analysis is part of a series of analyses of cofactors of HPV in the aetiology of cervical cancer...
  64. ncbi request reprint Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
    ..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
  65. ncbi request reprint Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:2677-84. 2006
    ..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
  66. ncbi request reprint [Assessment of HPV detection assays for use in cervical cancer screening programs]
    M Paz Cañadas
    Departamento de Biologia Molecular, Laboratorio de Análisis, General Lab, Barcelona, Espana
    Salud Publica Mex 48:373-8. 2006
    ..The different techniques for detection of this cancer need to be contrasted and validated for use in population screening...
  67. ncbi request reprint Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:431-9. 2004
    ..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV...
  68. ncbi request reprint Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 34:563-9. 2007
    ..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
  69. ncbi request reprint Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
    J Natl Cancer Inst 96:604-15. 2004
    ..We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program...
  70. ncbi request reprint HPV and circumcision: a biased, inaccurate and misleading meta-analysis
    Xavier Castellsague
    J Infect 55:91-3; author reply 93-6. 2007
  71. ncbi request reprint Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion
    Yali Zhai
    Department of Pathology, University of Michigan Medical School and Biostatistics Department, University of Michigan School of Public Health, Ann Arbor, Michigan 48109 2216, USA
    Cancer Res 65:6543-50. 2005
    ..Further studies of gene expression in preinvasive and invasive cervical cancers should assist with identification of additional critical factors mediating cervical cancer progression...
  72. ncbi request reprint Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18
    Jose C Prado
    Ludwig Institute for Cancer Research, Sao Paulo, Brazil
    Virology 340:95-104. 2005
    ....
  73. ncbi request reprint Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
    Nathaniel Rothman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Lancet Oncol 7:27-38. 2006
    ..We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph)...
  74. ncbi request reprint Can screening for cervical cancer be improved, especially in developing countries?
    Anthony B Miller
    Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany
    Int J Cancer 107:337-40. 2003
  75. ncbi request reprint [Screening history in women with infiltrating uterine cancer]
    Silvia de Sanjose
    Gac Sanit 20:166-7. 2006
  76. ncbi request reprint Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer
    Eduardo L Franco
    Division of Cancer Epidemiology, Departments of Oncology and Epidemiology and Biostatistics, McGill University, 546 Pine Avenue West, Montreal, Quebec, Canada
    Vaccine 24:S3/242-9. 2006
    ..The field of HPV and cervical cancer prevention has never been so multi-disciplinary. A new era has begun and the challenges are many...
  77. ncbi request reprint Organotypic co-cultures allow for immortalized human gingival keratinocytes to reconstitute a gingival epithelial phenotype in vitro
    Mariana Roesch-Ely
    Ear Nose and Throat Hospital, University of Heidelberg, Im Neuenheimer Feld 400, D 69120 Heidelberg, Germany
    Differentiation 74:622-37. 2006
    ..We are not aware of any other OCC system comprising of IHGK, which allows for site-specific expression of gingival epithelial markers. This substantiates reconstitution of a gingival epithelial phenotype in vitro...
  78. ncbi request reprint Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
    Thomas C Wright
    Department of Pathology, Columbia University, 630 W 168th Street, NY 10032, USA
    Vaccine 24:S3/251-61. 2006
    ..In this summary, we summarize the opinions of this expert group on how these advances can be introduced to provide the maximum benefit to women and to reduce the global burden of cervical cancer...
  79. pmc Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions
    Maxime J J Fleury
    INSERM U618, Tours, France
    Clin Vaccine Immunol 15:172-5. 2008
    ..Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay...